Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer

Ferroptosis-inducing agents are an emerging class of nonapoptotic, iron-dependent compounds for anticancer chemotherapy. We describe the synthesis of new aroyl diheterocyclyl pyrrole derivatives <b>2-21</b>. Compound <b>12</b> exhibited the most potent in vitro anticancer activity against breast cancer (BC), triple-negative breast cancer (TNBC), and colorectal cancer (CRC) cell lines, as well as significant efficacy in an HCT116 CRC xenograft model. Compound <b>12</b> showed typical hallmarks of ferroptosis in HCT116 cells from tumor tissues both in immunofluorescence and a qPCR gene assay and in the expression of ferroptosis inhibited proteins. Compound <b>12</b> significantly lowered GSH, NADP<sup>+</sup>, and NADPH levels. Furthermore, lactoperoxidase, malondialdehyde, and Fe(II) levels significantly increased in <b>12</b>-treated tissues, whereas superoxide dismutase concentrations decreased. Taken together, these results indicate that the antitumor activity of compound <b>12</b> was caused by the strong induction of ferroptosis. Given its high activity, compound <b>12</b> represents a promising therapeutic candidate for TNBC and CRC.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-08-11
DOI
https://doi.org/10.1021/acs.jmedchem.5c01561
Citations
1
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
0.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer

Mohammad Salik Zeya Ansari, Domiziana Masci, Chiara Bigogno, Wolfgang Link et al.
1 citations
Journal of Medicinal Chemistry
Cancer, Lipids, and Metabolism
0.94
article

Ferroptosis Induction by a New Pyrrole Derivative in Triple Negative Breast Cancer and Colorectal Cancer

Mohammad Salik Zeya Ansari, Domiziana Masci, Chiara Bigogno, Wolfgang Link, Claudio Sette, Lian Yang, Petra Cuřínová, Chiara Naro, Lele Ling, Maurice Santelli, Romano Silvestri, Antonio Coluccia, Lucía Jiménez, Giuseppe La Regina, Michela Puxeddu, Ernest Hamel, Giulio Dondio, Pietro Sciò, Te Liu, Claudia Colla
article en
1 citations

Abstract

Ferroptosis-inducing agents are an emerging class of nonapoptotic, iron-dependent compounds for anticancer chemotherapy. We describe the synthesis of new aroyl diheterocyclyl pyrrole derivatives <b>2-21</b>. Compound <b>12</b> exhibited the most potent in vitro anticancer activity against breast cancer (BC), triple-negative breast cancer (TNBC), and colorectal cancer (CRC) cell lines, as well as significant efficacy in an HCT116 CRC xenograft model. Compound <b>12</b> showed typical hallmarks of ferroptosis in HCT116 cells from tumor tissues both in immunofluorescence and a qPCR gene assay and in the expression of ferroptosis inhibited proteins. Compound <b>12</b> significantly lowered GSH, NADP<sup>+</sup>, and NADPH levels. Furthermore, lactoperoxidase, malondialdehyde, and Fe(II) levels significantly increased in <b>12</b>-treated tissues, whereas superoxide dismutase concentrations decreased. Taken together, these results indicate that the antitumor activity of compound <b>12</b> was caused by the strong induction of ferroptosis. Given its high activity, compound <b>12</b> represents a promising therapeutic candidate for TNBC and CRC.

Journal of Medicinal ChemistryVol. 68(16)
Università Cattolica del Sacro Cuore (IT), National Institutes of Health (US), Global Environment Facility (US), Shanghai Jiao Tong University (CN), Agostino Gemelli University Polyclinic (IT), Shanghai University of Traditional Chinese Medicine (CN), Frederick National Laboratory for Cancer Research (US), National Research Council (LK), Shanghai First People's Hospital (CN), National Cancer Institute (US), China Association of Acupuncture-Moxibustion (CN), Istituto Pasteur (IT), Universidad Autónoma de Madrid (ES), University of Chemistry and Technology, Prague (CZ)
Ministero della Salute, Sapienza Università di Roma, Associazione Italiana per la Ricerca sul Cancro, Università Cattolica del Sacro Cuore, State Administration of Traditional Chinese Medicine of the People's Republic of China, Ministero dell'Università e della Ricerca, European Regional Development Fund, Agencia Estatal de Investigación
Openalex Percentile: Top 22%
Cancer, Lipids, and Metabolism
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.